These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6753896)

  • 1. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
    Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure.
    Maslowski AH; Ikram H; Nicholls MG; Espiner EA
    Lancet; 1981 Jan; 1(8211):71-4. PubMed ID: 6109121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
    Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
    Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical improvement and hormonal changes in severe cardiac failure after captopril treatment.
    McGrath BP; Denham IM; Johnston CI
    Aust N Z J Med; 1981 Dec; 11(6):639-44. PubMed ID: 6277291
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A clinical study on treatment of refractory heart failure with oral captopril].
    Wang ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
    [No Abstract]   [Full Text] [Related]  

  • 13. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment of congestive heart failure with captopril.
    Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of captopril on plasma renin activity angiotensin II and aldosterone level in cardiac failure patients].
    Qin S; Ma C
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Feb; 19(1):29-31. PubMed ID: 2060462
    [No Abstract]   [Full Text] [Related]  

  • 19. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
    Sharpe DN; Coxon R
    Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.